These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 26556557)

  • 1. Critical Appraisal of Drug Promotional Literature in Accordance With WHO Guidelines.
    Rode SB; Salankar HV; Katole NT; Deshkar AT; Dadmal AA; Parate SV
    Cureus; 2022 Aug; 14(8):e27644. PubMed ID: 36072198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of perceptions and exposure of drug promotional literature among clinicians in a teaching hospital.
    Sharma S; Akhoon N; Moe HW; Nair DR; Shashidhar V
    Perspect Clin Res; 2021; 12(3):140-145. PubMed ID: 34386378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a Pharmaceutical Advertisement Analysis Module in a Drug Literature Evaluation Course.
    Amin MEK; Fattouh Y
    Am J Pharm Educ; 2017 Aug; 81(6):112. PubMed ID: 28970613
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals.
    Lankinen KS; Levola T; Marttinen K; Puumalainen I; Helin-Salmivaara A
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):789-95. PubMed ID: 15486957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Critical Analysis of Claims and Their Authenticity in Indian Drug Promotional Advertisements.
    Randhawa GK; Singh NR; Rai J; Kaur G; Kashyap R
    Adv Med; 2015; 2015():469147. PubMed ID: 26556557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Consistency between Claims and References Referred to in Pharmaceutical Advertising Brochures in the Kingdom of Saudi Arabia.
    Al-Tuhaifi TM; Awad AM; Abu-Zaid A; Eshaq AM; Mohammad N; Zebian SI; Sulaihim AG; Alburaidi Y; Fothan A; Kaweilh O; Rohra DK; Alamodi AA
    Cureus; 2019 Jan; 11(1):e3907. PubMed ID: 30931180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland.
    Santiago MG; Bucher HC; Nordmann AJ
    BMC Med Inform Decis Mak; 2008 Dec; 8():61. PubMed ID: 19117521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug advertisements published in Indian Medical Journals: Are they ethical?
    Charan J; Yadav P; Saxena D; Kantharia ND
    J Pharm Bioallied Sci; 2011 Jul; 3(3):403-6. PubMed ID: 21966161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiocolchicoside-induced liver injury.
    Efe C; Purnak T; Ozaslan E; Milanlioglu A
    Clinics (Sao Paulo); 2011; 66(3):521-2. PubMed ID: 21552685
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of rationality of promotional drug literature using World Health Organization guidelines.
    Mali SN; Dudhgaonkar S; Bachewar NP
    Indian J Pharmacol; 2010 Oct; 42(5):267-72. PubMed ID: 21206615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.
    Abrahamsen B; Eiken P; Eastell R
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5258-65. PubMed ID: 20843943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.
    Chrysant SG; Lee J; Melino M; Karki S; Heyrman R
    J Hum Hypertens; 2010 Nov; 24(11):730-8. PubMed ID: 20164847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model.
    Okada K; Tanaka H; Temporin K; Okamoto M; Kuroda Y; Moritomo H; Murase T; Yoshikawa H
    Exp Neurol; 2010 Apr; 222(2):191-203. PubMed ID: 20045411
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.